Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents.

@article{Yuasa2013TreatmentRA,
  title={Treatment responses and their predictors in patients with rheumatoid arthritis treated with biological agents.},
  author={Shino Yuasa and Harutaka Yamaguchi and Yoshinori Nakanishi and Shingo Kawaminami and Ryo Tabata and Nobuhiko Shimizu and Mitsuhiro Kohno and Teruki Shimizu and Junya Miyata and Mayuko Nakayama and Jun Kishi and Yuko Toyoda and Yasuhiko Nishioka and Kenji Tani},
  journal={The journal of medical investigation : JMI},
  year={2013},
  volume={60 1-2},
  pages={77-90}
}
Biological agents represent an important advancement in for the treatment of rheumatoid arthritis (RA), but there is a subset of patients who do not improve despite therapy. This study aimed to determine the efficacy of biological agents for RA and to identify clinical factors that are associated with their response. We studied 98 patients with RA who started an initiating biological agent which was selected from infliximab, etanercept, adalimumab and tociliximab at 4 medical institutions… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Similar Papers

Loading similar papers…